Analyst Ratings for Thermo Fisher Scientific (TMO)
TMO Rating Summary
TMO Price Target Summary
- Highest: $95.00 (Jefferies)
- Lowest: $49.00 (Goldman Sachs)
- Average: $70.42
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$70.42 (-18.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | Jefferies | New Coverage | Buy (N/A) |
95.00 (N/A) |
82.44 | 86.28 | 4.66% | Details |
| 4/16/2013 | Mizuho Securities | Upgrade | Buy (Neutral) |
90.00 (65.00) |
78.58 | 86.28 | 9.8% | Details |
| 2/1/2013 | JPMorgan | Upgrade | Overweight (Neutral) |
80.00 (70.00) |
72.14 | 86.28 | 19.6% | Details |
| 10/5/2012 | Wells Fargo | Upgrade | Outperform (Market Perform) |
72.50 (57.50) |
60.30 | 86.28 | 43.08% | Details |
| 8/21/2012 | Barclays | New Coverage | Overweight (N/A) |
60.00 (N/A) |
56.56 | 86.28 | 52.55% | Details |
| 8/9/2012 | WallachBeth Capital | New Coverage | Buy (N/A) |
68.00 (N/A) |
57.30 | 86.28 | 50.58% | Details |
| 7/10/2012 | ISI Group » Updated 10/8/2012 |
New Coverage | Buy (N/A) |
67.00 (61.50) |
51.58 | 86.28 | 67.27% | Details |
| 3/6/2012 | Morgan Stanley | New Coverage | Overweight (N/A) |
66.00 (N/A) |
56.56 | 86.28 | 52.55% | Details |
| 1/6/2012 | Cantor Fitzgerald | New Coverage | Buy (N/A) |
57.00 (N/A) |
46.34 | 86.28 | 86.19% | Details |
| 12/15/2011 | Goldman Sachs » Updated 1/20/2012 |
Downgrade | Neutral (N/A) |
49.00 (N/A) |
43.75 | 86.28 | 97.21% | Details |
| 10/27/2011 | Lazard Capital | Downgrade | Neutral (N/A) |
N/A (N/A) |
48.36 | 86.28 | 78.41% | Details |
| 10/5/2011 | Oppenheimer » Updated 10/27/2011 |
New Coverage | Outperform (N/A) |
59.00 (N/A) |
50.57 | 86.28 | 70.61% | Details |
| 11/10/2010 | Auriga » Updated 5/24/2012 |
Upgrade | Buy (N/A) |
65.00 (N/A) |
51.40 | 86.28 | 67.86% | Details |
| 10/13/2010 | Gleacher & Co. | New Coverage | Buy (N/A) |
N/A (N/A) |
48.46 | 86.28 | 78.04% | Details |
